ClinVar Genomic variation as it relates to human health
NM_002863.5(PYGL):c.1900G>C (p.Asp634His)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
Uncertain significance(7); Likely benign(2)
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_002863.5(PYGL):c.1900G>C (p.Asp634His)
Variation ID: 21331 Accession: VCV000021331.42
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 14q22.1 14: 50911799 (GRCh38) [ NCBI UCSC ] 14: 51378517 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline May 3, 2013 Oct 20, 2024 Jan 18, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_002863.5:c.1900G>C MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_002854.3:p.Asp634His missense NM_001163940.2:c.1798G>C NP_001157412.1:p.Asp600His missense NC_000014.9:g.50911799C>G NC_000014.8:g.51378517C>G NG_012796.1:g.37732G>C - Protein change
- D634H, D600H
- Other names
-
p.Asp634His
- Canonical SPDI
- NC_000014.9:50911798:C:G
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
-
0.00140 (G)
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
1000 Genomes Project 0.00140
1000 Genomes Project 30x 0.00156
Trans-Omics for Precision Medicine (TOPMed) 0.00383
The Genome Aggregation Database (gnomAD) 0.00435
NHLBI Exome Sequencing Project (ESP) Exome Variant Server 0.00454
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
PYGL | - | - |
GRCh38 GRCh37 |
347 | 366 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Conflicting interpretations of pathogenicity (8) |
criteria provided, conflicting classifications
|
Jan 18, 2024 | RCV000020496.22 | |
Conflicting interpretations of pathogenicity (3) |
criteria provided, conflicting classifications
|
Apr 1, 2023 | RCV000675363.20 | |
PYGL-related disorder
|
Uncertain significance (1) |
no assertion criteria provided
|
Sep 20, 2024 | RCV003934845.2 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Uncertain significance
(Mar 13, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Eurofins Ntd Llc (ga)
Accession: SCV000226464.5
First in ClinVar: Jun 29, 2015 Last updated: Aug 05, 2018 |
Number of individuals with the variant: 11
Sex: mixed
|
|
Uncertain significance
(Apr 27, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
Glycogen storage disease, type VI
Affected status: unknown
Allele origin:
germline
|
Illumina Laboratory Services, Illumina
Accession: SCV001270154.1
First in ClinVar: May 31, 2020 Last updated: May 31, 2020 |
Comment:
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, … (more)
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. (less)
|
|
Uncertain significance
(Oct 03, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Not provided
Affected status: unknown
Allele origin:
germline
|
Mayo Clinic Laboratories, Mayo Clinic
Accession: SCV000801029.2
First in ClinVar: Aug 05, 2018 Last updated: Jan 26, 2024 |
Comment:
BS1, PP3
Number of individuals with the variant: 2
|
|
Uncertain significance
(Jul 27, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Glycogen storage disease, type VI
Affected status: unknown
Allele origin:
germline
|
Revvity Omics, Revvity
Accession: SCV003818062.2
First in ClinVar: Mar 04, 2023 Last updated: Feb 04, 2024 |
|
|
Uncertain significance
(Jan 18, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Glycogen storage disease, type VI
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV000752191.8
First in ClinVar: May 03, 2013 Last updated: Feb 20, 2024 |
Comment:
This sequence change replaces aspartic acid, which is acidic and polar, with histidine, which is basic and polar, at codon 634 of the PYGL protein … (more)
This sequence change replaces aspartic acid, which is acidic and polar, with histidine, which is basic and polar, at codon 634 of the PYGL protein (p.Asp634His). This variant is present in population databases (rs35026927, gnomAD 0.6%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with glycogen storage disease and/or PYGL-related disease (PMID: 17705025). ClinVar contains an entry for this variant (Variation ID: 21331). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PYGL protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. (less)
|
|
Likely benign
(Sep 18, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Glycogen storage disease, type VI
Affected status: unknown
Allele origin:
germline
|
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Accession: SCV000604993.2
First in ClinVar: Jun 29, 2015 Last updated: Feb 20, 2024 |
|
|
Uncertain significance
(May 28, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
Glycogen storage disease, type VI
Affected status: unknown
Allele origin:
unknown
|
Mendelics
Accession: SCV001139454.1
First in ClinVar: Jan 13, 2020 Last updated: Jan 13, 2020 |
|
|
Uncertain significance
(Sep 01, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Glycogen storage disease, type VI
Affected status: yes
Allele origin:
germline
|
3billion
Accession: SCV002572773.1
First in ClinVar: Sep 17, 2022 Last updated: Sep 17, 2022 |
Comment:
The variant is observed in the gnomAD v2.1.1 ( https://gnomad.broadinstitute.org ) dataset at total allele frequency of 0.380%. In silico tool predictions suggest damaging effect … (more)
The variant is observed in the gnomAD v2.1.1 ( https://gnomad.broadinstitute.org ) dataset at total allele frequency of 0.380%. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.98; 3Cnet: 0.45). Same nucleotide change resulting in same amino acid change has been previously reported to be associated with PYGL-related disorder with insufficient/conflicting evidence (PMID: 31768638 / ClinVar ID: VCV000021331). A different missense change at the same codon (p.Asp634Gly) has been reported to be associated with PYGL-related disorder (PMID: 31768638). However the evidence of pathogenicity is insufficient at this time. Therefore, this variant is classified as uncertain significance according to the recommendation of ACMG/AMP guideline. (less)
Clinical Features:
Stenosis of lacrimal punctum (present) , Lower limb asymmetry (present) , Global developmental delay (present) , Hepatomegaly (present)
|
|
Likely benign
(Apr 01, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
CeGaT Center for Human Genetics Tuebingen
Accession: SCV004010280.12
First in ClinVar: Jul 16, 2023 Last updated: Oct 20, 2024 |
Comment:
PYGL: PP3, BS2
Number of individuals with the variant: 1
|
|
Uncertain significance
(Sep 20, 2024)
|
no assertion criteria provided
Method: clinical testing
|
PYGL-related condition
Affected status: unknown
Allele origin:
germline
|
PreventionGenetics, part of Exact Sciences
Accession: SCV004748656.2
First in ClinVar: Mar 16, 2024 Last updated: Oct 08, 2024 |
Comment:
The PYGL c.1900G>C variant is predicted to result in the amino acid substitution p.Asp634His. This variant has been reported in individuals with Glycogen storage disease … (more)
The PYGL c.1900G>C variant is predicted to result in the amino acid substitution p.Asp634His. This variant has been reported in individuals with Glycogen storage disease VI (Beauchamp et al. 2007. PubMed ID: 17705025; Aeppli et al 2019. PubMed ID: 31768638). It was also reported in the heterozygous state in two individuals with possible GSD type VI, however, no second PYGL variants were observed (Ghosh et al. 2017. PubMed ID: 28468868; Degrassi et al. 2021. PubMed ID: 32505569). This variant is reported in 0.65% of alleles in individuals of European (Non-Finnish) descent including two homozygotes in gnomAD. and while this relatively high minor allele frequency argues against pathogenicity, we have observed the c.1900G>C variant in the heterozygous state in more than twenty symptomatic patients at PreventionGenetics (Internal Data). In at least ten of these patients, we found a second potential causative variant in PYGL. Family testing for several of these patients suggests that the variants followed expected Mendelian inheritance patterns for a recessive disorder. While we suspect this variant may possibly be benign, at this time its clinical significance is uncertain due to the absence of conclusive functional and genetic evidence. (less)
|
|
not provided
(-)
|
no classification provided
Method: literature only
|
Glycogen storage disease, type VI
Affected status: not provided
Allele origin:
unknown
|
GeneReviews
Accession: SCV000040946.3
First in ClinVar: Apr 04, 2013 Last updated: Oct 01, 2022 |
|
|
not provided
(-)
|
no classification provided
Method: phenotyping only
|
Glycogen storage disease, type VI
Affected status: unknown
Allele origin:
unknown
|
GenomeConnect - Invitae Patient Insights Network
Accession: SCV004228531.1
First in ClinVar: Jan 26, 2024 Last updated: Jan 26, 2024 |
Comment:
Variant interpreted as Uncertain significance and reported on 12-21-2018 by Lab Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the … (more)
Variant interpreted as Uncertain significance and reported on 12-21-2018 by Lab Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. (less)
Clinical Features:
Asthma (present) , Decreased response to growth hormone stimulation test (present) , Pregnancy history (present) , Premature birth (present)
Age: 0-9 years
Sex: female
Method: Gene Panel Sequencing
Testing laboratory: Invitae
Date variant was reported to submitter: 2018-12-21
Testing laboratory interpretation: Uncertain significance
|
|
click to load more click to collapse |
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Integration of whole genome sequencing into a healthcare setting: high diagnostic rates across multiple clinical entities in 3219 rare disease patients. | Stranneheim H | Genome medicine | 2021 | PMID: 33726816 |
Liver histology in children with glycogen storage disorders type VI and IX. | Degrassi I | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2021 | PMID: 32505569 |
Glycogen storage disease type VI can progress to cirrhosis: ten Chinese patients with GSD VI and a literature review. | Lu SQ | Journal of pediatric endocrinology & metabolism : JPEM | 2020 | PMID: 32892177 |
Glycogen storage disease type VI: clinical course and molecular background. | Aeppli TR | European journal of pediatrics | 2020 | PMID: 31768638 |
Glycogen Storage Disease Type VI. | Adam MP | - | 2019 | PMID: 20301760 |
Diagnosing childhood-onset inborn errors of metabolism by next-generation sequencing. | Ghosh A | Archives of disease in childhood | 2017 | PMID: 28468868 |
Normoglycemic Ketonemia as Biochemical Presentation in Ketotic Glycogen Storage Disease. | Hoogeveen IJ | JIMD reports | 2016 | PMID: 26526422 |
Personalized genomic disease risk of volunteers. | Gonzalez-Garay ML | Proceedings of the National Academy of Sciences of the United States of America | 2013 | PMID: 24082139 |
High frequency of missense mutations in glycogen storage disease type VI. | Beauchamp NJ | Journal of inherited metabolic disease | 2007 | PMID: 17705025 |
http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=PYGL | - | - | - | - |
Text-mined citations for rs35026927 ...
HelpRecord last updated Nov 03, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.